首页> 外文学位 >Feasibility study on the medical isotopes production with solution target using OSTR: (99)Mo and related isotopes.
【24h】

Feasibility study on the medical isotopes production with solution target using OSTR: (99)Mo and related isotopes.

机译:使用OSTR:(99)Mo和相关同位素以溶液为目标生产医学同位素的可行性研究。

获取原文
获取原文并翻译 | 示例

摘要

Molybdenum-99 (99Mo) is the parent nuclide of Technetium-99m (99mTc), a radioisotope which is widely used in nuclear medicine. 99Mo is produced from the fission of 235U or the irradiation of 98Mo. This study shows the feasibility of the using an 'aqueous homogeneous uranium solution target' for the production of a medical isotope, 99Mo. Some of the advantages that the solution target has over a solid target include the inherent reactor safety features offered by large negative temperature and power reactivity coefficients, the fabrication convenience, the straightforward extraction process, and a low volume of waste generated.;To evaluate the core configuration and the production rate of 99Mo, a three-dimensional model of the Oregon State University TRIGA Reactor (OSTR) core was developed for use with the Monte Carlo N-Particle Transport Code (MCNP) and then verified by comparing with the measured values. Two values are in good agreement within one percent in the keffective values calculated.;Two types of solution targets are analyzed for the OSTR. The first one has the same outer-dimensions as an OSTR fuel element but is filled with a uranium solution. The other is the continuous flow target system (CFTS) like solution fuel reactors. Uranyl nitrate and uranyl sulfate solutions enriched to 20% or 93% are investigated as a target material without raising any safety concern to the OSTR operation. A seven-day irradiation of ten tube-type-93% enriched uranyl nitrate solution targets would produce 43% of the 99Mo required in the US for one week. The CFTS would generate 31% of the required 99Mo in a 7-day cycle. The conceptual chemical extraction processes for irradiated solution targets are developed. This work also includes an analysis of nuclear safety issues such as the radiolytic gas, thermal hydraulics, the waste, and the radiological impacts of an accident.;The production of 99Mo in the OSTR with the uranium solution is technically feasible as demonstrated in this work. The use of the uranium solution would increase the production efficiency by good neutron economy, reduction of the processing period, through the reuse of uranium, and by minimizing the waste generation.
机译:钼99(99Mo)是Tech 99m(99mTc)的母核,后者是一种广泛用于核医学的放射性同位素。 99Mo是由235U的裂变或98Mo的辐射产生的。这项研究表明了使用“均质铀水溶液靶材”生产医学同位素99Mo的可行性。解决方案目标优于固体目标的一些优点包括:反应器固有的安全特性,包括大的负温度和功率反应系数,制造方便,提取过程简单,产生的废物少。开发了俄勒冈州州立大学TRIGA反应堆(OSTR)核的三维模型,并与蒙特卡罗N粒子传输代码(MCNP)一起使用,设计了核结构和99Mo的生产率。 。在计算出的有效值的百分之一以内,两个值吻合良好。对OSTR分析了两种解决方案目标。第一个具有与OSTR燃料元件相同的外部尺寸,但填充有铀溶液。另一个是连续流目标系统(CFTS),例如溶液燃料反应堆。研究了浓缩至20%或93%的硝酸铀酰和硫酸铀酰溶液作为目标材料,而没有引起OSTR操作的任何安全隐患。对10个管式93%浓缩的硝酸铀酰溶液靶标进行7天的辐射,将产生美国一周需要的43%的99Mo。 CFTS将在7天的周期内生成所需的99Mo的31%。开发了用于辐照溶液目标的概念性化学提取工艺。这项工作还包括对核安全问题的分析,例如放射性气体,热工水力,废物和事故的放射学影响。这项工作证明,在OSTR中使用铀溶液生产99Mo在技术上是可行的。铀溶液的使用将通过良好的中子经济性,缩短处理时间,通过铀的再利用以及减少废物的产生来提高生产效率。

著录项

  • 作者

    Baik, Seung-Hyuk.;

  • 作者单位

    Oregon State University.;

  • 授予单位 Oregon State University.;
  • 学科 Engineering Biomedical.;Engineering Nuclear.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 203 p.
  • 总页数 203
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号